TORREFARMA activity focuses on the development and delivery of pharmaceutical products manufactured with the collaboration of various manufacturers located in Europe.
TORREFARMA has developed or co-developed generic drugs, and is increasing its portfolio of products every year. At the moment the focus of our development follows therapeutic criteria (Cancer, Alzheimer's disease, and hypertension), or technological criteria.See Generics
Irongrowth line. Nutritional supplements specially designed to cover all the needs of mothers and children, from pregnancy (Irongest) to breastfeeding (Ironlact) and child growth (Ironkid). All these multivitaminic products contain also high amount of DHA and a patented microencapsulated iron.See Nut.Supplements